P3H2

prolyl 3-hydroxylase 2, the group of Prolyl 3-hydroxylase family

Basic information

Region (hg38): 3:189956728-190122437

Previous symbols: [ "LEPREL1" ]

Links

ENSG00000090530NCBI:55214OMIM:610341HGNC:19317Uniprot:Q8IVL5AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • myopia, high, with cataract and vitreoretinal degeneration (Strong), mode of inheritance: AR
  • myopia, high, with cataract and vitreoretinal degeneration (Moderate), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Myopia, high, with cataract and vitreoretinal degenerationARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingOphthalmologic21885030; 24172257; 25469533

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the P3H2 gene.

  • not provided (29 variants)
  • Myopia, high, with cataract and vitreoretinal degeneration (3 variants)
  • Rare isolated myopia (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the P3H2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
113
clinvar
9
clinvar
123
missense
260
clinvar
5
clinvar
6
clinvar
271
nonsense
14
clinvar
3
clinvar
3
clinvar
20
start loss
1
clinvar
1
frameshift
16
clinvar
1
clinvar
1
clinvar
18
inframe indel
19
clinvar
19
splice donor/acceptor (+/-2bp)
8
clinvar
1
clinvar
9
splice region
14
21
4
39
non coding
4
clinvar
96
clinvar
63
clinvar
163
Total 30 12 290 214 78

Highest pathogenic variant AF is 0.0000658

Variants in P3H2

This is a list of pathogenic ClinVar variants found in the P3H2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
3-189957700-AAGAG-A Benign (Sep 13, 2019)1230099
3-189957700-A-AAG Benign (Aug 26, 2019)1280894
3-189957700-A-AAGAG Benign (Nov 06, 2019)1277801
3-189957700-A-AAGAGAG Likely benign (Aug 24, 2019)1220167
3-189957700-A-AAGAGAGAG Benign (Aug 31, 2019)1267579
3-189957700-A-AAGAGAGAGAG Likely benign (Feb 06, 2020)1195289
3-189957778-C-T Likely benign (Jan 16, 2019)1198632
3-189957926-T-C Inborn genetic diseases Uncertain significance (Mar 29, 2023)2530883
3-189957933-G-A Likely benign (Oct 03, 2022)1658776
3-189957972-A-C Uncertain significance (Dec 15, 2021)1521725
3-189957985-TC-AA Uncertain significance (Jan 14, 2022)2082316
3-189957995-G-A Uncertain significance (Jul 28, 2019)956368
3-189958000-C-T Inborn genetic diseases Uncertain significance (Jun 13, 2024)941936
3-189958001-G-A P3H2-related disorder Uncertain significance (Sep 15, 2023)844528
3-189958007-G-C Uncertain significance (Sep 07, 2022)1371159
3-189958017-CA-C Likely benign (Jun 20, 2022)1630677
3-189963671-C-T Benign (Feb 14, 2019)1235572
3-189963695-C-T Benign (Jun 28, 2018)1243765
3-189963769-C-G Benign (Jun 28, 2018)1241801
3-189963938-T-C Likely benign (Jul 17, 2023)1670921
3-189963942-C-A Likely benign (Aug 10, 2023)1101629
3-189963942-C-T Benign (Jan 22, 2024)1164190
3-189963943-G-A Likely benign (Oct 17, 2022)1965302
3-189963947-G-A Likely benign (Aug 22, 2022)1957506
3-189963949-GA-G Likely benign (Oct 21, 2021)1648263

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
P3H2protein_codingprotein_codingENST00000319332 15165710
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
7.79e-210.013312560601421257480.000565
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.2353893761.030.00002014529
Missense in Polyphen11098.8961.11231182
Synonymous-0.6431551451.070.000007921383
Loss of Function0.7713439.20.8670.00000227451

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0008440.000840
Ashkenazi Jewish0.000.00
East Asian0.0001630.000163
Finnish0.0003240.000323
European (Non-Finnish)0.0008270.000827
Middle Eastern0.0001630.000163
South Asian0.0004610.000457
Other0.0006520.000652

dbNSFP

Source: dbNSFP

Function
FUNCTION: Prolyl 3-hydroxylase that catalyzes the post- translational formation of 3-hydroxyproline on collagens (PubMed:18487197). Contributes to proline 3-hydroxylation of collagen COL4A1 and COL1A1 in tendons, the eye sclera and in the eye lens capsule (By similarity). Has high activity with the type IV collagen COL4A1, and lower activity with COL1A1 (PubMed:18487197). Catalyzes hydroxylation of the first Pro in Gly-Pro-Hyp sequences where Hyp is 4-hydroxyproline (PubMed:18487197). Has no activity on substrates that lack 4- hydroxyproline in the third position (PubMed:18487197). {ECO:0000250|UniProtKB:Q8CG71, ECO:0000269|PubMed:18487197}.;
Pathway
Collagen biosynthesis and modifying enzymes;Collagen formation;Extracellular matrix organization (Consensus)

Recessive Scores

pRec
0.132

Intolerance Scores

loftool
rvis_EVS
-0.55
rvis_percentile_EVS
19.8

Haploinsufficiency Scores

pHI
0.142
hipred
N
hipred_score
0.394
ghis
0.501

Essentials

essential_gene_CRISPR
essential_gene_CRISPR2
essential_gene_gene_trap
N
gene_indispensability_pred
gene_indispensability_score

Mouse Genome Informatics

Gene name
P3h2
Phenotype
mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; homeostasis/metabolism phenotype;

Gene ontology

Biological process
negative regulation of cell population proliferation;peptidyl-proline hydroxylation;collagen metabolic process;oxidation-reduction process
Cellular component
basement membrane;endoplasmic reticulum;endoplasmic reticulum lumen;Golgi apparatus;sarcoplasmic reticulum
Molecular function
iron ion binding;procollagen-proline 3-dioxygenase activity;L-ascorbic acid binding